OR

Browse By

Innovations in peptide-based drug design (2011–2014)

Abstract:
The overall aim of this project is to develop innovative generic strategies to facilitate the development of peptides as new drugs. Peptides are naturally occurring sequences of amino acids, and are the most abundant organic molecules in cells, with fundamental roles in defining life, ageing, disease and death in all organisms. They therefore are regarded as important drug leads, but because synthetic peptides have limited stability and bioavailability this promise has so far not been realised. In this project we aim to overcome these major limitations, by developing strategies to stabilise peptides, and then applying the findings to selected targets to demonstrate how peptides can become the next generation of pharmaceuticals.
Grant type:
ARC Linkage Projects
Researchers:

  • Professor David Craik

    UQ Laureate Fellow - GL
    Institute for Molecular Bioscience
    UQ Laureate Fellow - GL
    Institute for Molecular Bioscience
    Centre Director of ARC COE for Inno
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    Affiliate Professor of School of Bi
    School of Biomedical Sciences
    Faculty of Medicine

  • Professor David Fairlie

    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    of Institute for Molecular Bioscien
    Institute for Molecular Bioscience
Funded by:
Australian Research Council